Sign In
Buy CYDY
$0.276
-0.0143 (-4.93%)
At Close: Jun 03, 2026
NEW YORK, May 5, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021,
CytoDyn strikes agreement with AEIH in Brazil to run two coronavirus trials using its flagship drug leronlimab
07:57am, Wednesday, 05'th May 2021
CytoDyn Inc (OTCQB:CYDY) announced that it has struck an agreement to partner with the Academic Research Organization (ARO) - Albert Einstein Israelite Hospital (AEIH), in São Paulo, Brazil to run t
Interim analysis for critically ill population will be conducted when enrollment reaches about 120 patients or 40% of the approximate 300 patients
New York, New York--(Newsfile Corp. - May 4, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTCQB: CYDY) alleging that the
New York, New York--(Newsfile Corp. - May 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cyto
CytoDyn to Hold Webcast on May 5 to Provide Update on Multiple Initiatives
09:05am, Monday, 03'rd May 2021
VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140)
VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (Vyrologix or PRO 140)
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021, inclusive
Radnor, Pennsylvania--(Newsfile Corp. - May 1, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuit has been filed against CytoDyn In
New York, New York--(Newsfile Corp. - April 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of C
New Orleans, Louisiana--(Newsfile Corp. - April 29, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have
New York, New York--(Newsfile Corp. - April 29, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytoDyn Inc. (OTCQB: CYDY) between March 27, 20
New York, New York--(Newsfile Corp. - April 29, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTCQB: CYDY) alleging that
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY
09:34pm, Wednesday, 28'th Apr 2021
New York, New York--(Newsfile Corp. - April 28, 2021) - Pomerantz LLP is investigating claims on behalf of investors of CytoDyn Inc. ("CytoDyn" or the "Company") (OTCMKTS: CYDY). Such investors are ad
New York, New York--(Newsfile Corp. - April 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of C
